DNA hypomethylation of interleukin 8 in clear cell renal cell carcinoma

Oncology Letters

Volumn 5, Issue 1, 2012, Pages 39-42

  Yoo, Koo Han ^a   Park, Yong Koo ^a   Chang, Sung Goo ^a  

^a Kyung Hee University Hospital   (South Korea)

Author keywords

Carcinoma; DNA methylation; Interleukin 8; Renal cell

Indexed keywords

INTERLEUKIN 8;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; DNA METHYLATION; FEMALE; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MALE; NEPHRECTOMY; SEQUENCE ANALYSIS; VALIDATION PROCESS;

EID: 84869045789     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.992     Document Type: Article

References (18)

1. Waugh DJ and Wilson C: The interleukin-8 pathway in cancer. Clin Cancer Res 14: 6735-6741, 2008.
2. Vandercappellen J, Van Damme J and Struyf S: The role of CXC chemokines and their receptors in cancer. Cancer Lett 267: 226-244, 2008.
3. Martin D, Galisteo R and Gutkind JS: CXCL8/IL8 stimulates vascular endothelial growth factor (VEGF) expression and the autocrine activation of VEGFR2 in endothelial cells by activating NFkappa B through the CBM (Carma3/Bcl10/Malt1) complex. J Biol Chem 284: 6038-6042, 2009.
4. Djordjevic G, Mozetic V, Mozetic DV, et al: Prognostic significance of vascular endothelial growth factor expression in clear cell renal cell carcinoma. Pathol Res Pract 203: 99-106, 2007.
5. Yegnasubramanian S, Haffner MC, Zhang Y, et al: DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity. Cancer Res 68: 8954-8967, 2008.
6. Karpf AR and Matsui S: Genetic disruption of cytosine DNA methyltransferase enzymes induces chromosomal instability in human cancer cells. Cancer Res 65: 8635-8639, 2005.
7. Kim GY, Park JH, Kim YW, Jung WW, Unni KK and Park YK: Absence of amplification of HER-2/neu (c-erb B-2) gene in Ewing's sarcoma: a real-time polymerase chain reaction method. Pathol Res Pract 200: 663-667, 2004.
8. Bibikova M, Lin Z, Zhou L, et al: High-throughput DNA methylation profiling using universal bead arrays. Genome Res 16: 383-393, 2006.
9. Herman JG, Graff JR, Myöhänen S, Nelkin BD and Baylin SB: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93: 9821-9826, 1996.
10. Yoo KH, Park YK, Kim HS, Jung WW and Chang SG: Epigenetic inactivation of HOXA5 and MSH2 gene in clear cell renal cell carcinoma. Pathol Int 60: 661-666, 2010.
11. Jones PA and Laird PW: Cancer epigenetics comes of age. Nat Genet 21: 163-167, 1999.
12. Eden A, Gaudet F, Waghmare A and Jaenisch R: Chromosomal instability and tumors promoted by DNA hypomethylation. Science 300: 455, 2003.
13. Suzuki K, Suzuki I, Leodolter A, et al: Global DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage. Cancer Cell 9: 199-207, 2006.
14. Cadieux B, Ching TT, Vanden Berg SR and Costello JF: Genome-wide hypomethylation in human glioblastomas associated with specific copy number alteration, methylenetetrahydrofolate reductase allele status, and increased proliferation. Cancer Res 66: 8469-8476, 2006.
15. Xie K: Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev 12: 375-391, 2001.
16. Strieter RM, Belperio JA, Phillips RJ and Keane MP: CXC chemokines in angiogenesis of cancer. Semin Cancer Biol 14: 195-200, 2004.
17. Dimberg J, Ström K, Löfgren S, Zar N, Lindh M and Matussek A: DNA promoter methylation status and protein expression of interleukin-8 in human colorectal adenocarcinomas. Int J Colorectal Dis 27: 709-714, 2011.
18. De Larco JE, Wuertz BR, Yee D, Rickert BL and Furcht LT: Atypical methylation of the interleukin-8 gene correlates strongly with the metastatic potential of breast carcinoma cells. Proc Natl Acad Sci USA 100: 13988-13993, 2003.